Comparison between Thyrocare Technologies IPO and Ujjivan Financial IPO.
Thyrocare Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ujjivan Financial IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Thyrocare Technologies IPO is up to ₹479.21 Cr whereas the issue size of the Ujjivan Financial IPO is up to ₹882.50 Cr. The final issue price of Thyrocare Technologies IPO is ₹446.00 per share and of Ujjivan Financial IPO is ₹210.00 per share.
| Thyrocare Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹420.00 per share | ₹207.00 per share |
| Issue Price (Upper) | ₹446.00 per share | ₹210.00 per share |
| Issue Price (Final) | ₹446.00 per share | ₹210.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 33 shares | 70 shares |
| Fresh Issue Size | 0 shares | 1,70,55,277 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹358.16 Cr |
| OFS Issue Size | 1,07,44,708 shares | 2,49,68,332 shares |
| OFS Issue Size (Amount) | up to ₹479.21 Cr | up to ₹524.33 Cr |
| Issue Size Total | 1,07,44,708 shares | 4,20,23,609 shares |
| Issue Size Total (Amount) | up to ₹479.21 Cr | up to ₹882.50 Cr |
Thyrocare Technologies IPO opens on Apr 27, 2016, while Ujjivan Financial IPO opens on Apr 28, 2016. The closing date of Thyrocare Technologies IPO and Ujjivan Financial IPO is Apr 29, 2016, and May 02, 2016, respectively.
| Thyrocare Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Anchor Bid Date | Apr 26, 2016 | Apr 27, 2016 |
| Issue Open | Apr 27, 2016 | Apr 28, 2016 |
| Issue Close | Apr 29, 2016 | May 02, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 09, 2016 | May 10, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Thyrocare Technologies IPO P/E ratio is , as compared to Ujjivan Financial IPO P/E ratio of .
| Thyrocare Technologies IPO | Ujjivan Financial IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 64.96 | |||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2396.07 Cr. | ₹2483.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.37% | 10.29% |
In the Thyrocare Technologies IPO Retail Individual Investors (RII) are offered 37,60,648 shares while in Ujjivan Financial IPO retail investors are offered 37,60,648 shares. Qualified Institutional Buyers (QIB) are offered 21,48,942 shares in Thyrocare Technologies IPO and 84,04,722 shares in Ujjivan Financial IPO.
| Thyrocare Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| Anchor Investor Reservation | 32,23,411 shares | 1,26,07,081 shares |
| Market Maker Reservation | ||
| QIB | 21,48,942 shares | 84,04,722 shares |
| NII | 16,11,707 shares | 63,03,542 shares |
| RII | 37,60,648 shares | 1,47,08,264 shares |
| Employee | ||
| Others | ||
| Total | 1,07,44,708 shares | 4,20,23,609 shares |
Thyrocare Technologies IPO subscribed 73.55x in total, whereas Ujjivan Financial IPO subscribed 40.69x.
| Thyrocare Technologies IPO | Ujjivan Financial IPO | |
|---|---|---|
| QIB (times) | 73.18x | 33.84x |
| NII (times) | 225.30x | 135.45x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.73x | 4.02x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 73.55x | 40.69x |
